Delivery Order SPE2DB22D2206-SPE2DB25FHV94
- Not listed
- The Defense Logistics Agency awarded a $1,577.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexmedetomidine 200 MCG/2 ML in 2 ML vials. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value transaction within the company's broader pharmaceutical supply portfolio...
- The Defense Logistics Agency awarded a delivery order valued at $2,631.60 to AmerisourceBergen Drug Corp for the supply of Dexmedetomidine 200mcg/50mL in normal saline, 50mL units. This firm fixed price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dexmedetomidine is a sedative and analgesic medication commonly used in military and federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Dexmedetomidine 400 micrograms per 100 milliliters in normal saline solution (100 milliliters). The contract has a ceiling value of $11,209.75 and is structured as a firm fixed price delivery order with an ultimate completion date of May 21, 2025. This award was not designated as a set-aside contract, indicating it was competitively awarded. The place of performance is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The contract has a ceiling value of $1,708.81 and a period of performance through March 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,627.13, is for the delivery of Dexmedetomidine 200 mcg/2 mL 2 mL, a medication used for sedation. The contract has a completion date of December 14, 2023 and is a Firm Fixed Price Delivery Order. The contract is not set aside for any specific business category....
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,203,919 units of the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The order has a ceiling value of $4,104.39 and a period of performance through April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568233987 - Dexmedetomidine 200 mcg/2 ml 2 ml, a medication used for sedation. The contract has a firm fixed price of $1,244.00 and a completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,400.14 by the Medical Supply Chain on September 5, 2025. The contract calls for the delivery of dexmedetomidine 400 micrograms per 100 milliliters in a 100-milliliter saline solution package, with an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under open competition...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $2,026.56 award is for the delivery of a pharmaceutical product, Dexmedetomidin 400mcg/100ml-NS 100ml, with a completion date of February 6, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA,...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,334.90, is for the delivery of Dexmedetomidine 200 mcg/2 ml 2 ml medical supplies. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHV94Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,613.79 to AmerisourceBergen Drug Corp for the supply of Dexmedetomidine 400 mcg/100 mL in 100 mL vials. This competitively awarded, firm fixed-price contract was issued on July 11, 2025, with an ultimate completion date of July 14, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexmedetomidine is a sedative and analgesic medication commonly used in medical and veterinary settings for anesthesia support and critical care applications. This delivery order represents a small-value transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.9 billion global pharmaceutical supply vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen regularly fulfills DLA requirements across a broad spectrum of pharmaceutical products and medical supplies supporting military healthcare systems and the Defense Health Agency. The company's extensive federal contracting history demonstrates consistent capability to deliver specialized medications and medical commodities through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/11/25 |